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Tuberculosis (TB) is the leading cause of death from a single infectious agent in Korea. In this study, we
compared the proteins present in culture filtrates fromMycobacterium tuberculosis strain K, which is the dominant
clinical isolate in Korea, with those present in culture filtrates from M. tuberculosis H37Rv. Several differences in
expression were detected between the two strains for those proteins with a molecular mass of <20 kDa. ESAT-6,
HSP-X, and CFP-10 were found to be abundantly expressed in the strain K culture filtrates by liquid chromatog-
raphy-electrospray ionization-time of flight mass spectrometry. The serodiagnostic potentials of recombinant
antigens rESAT-6, rHSP-X, and rCFP-10 and two native antigens (Ag85 and PstS1) were evaluated by Western blot
analysis and enzyme-linked immunosorbent assay (ELISA) using sera collected from 46 TB patients with active
disease and 46 healthy controls. As for our ELISA results, HSP-X was superior to the other antigens in terms of
sensitivity when a single antigen was employed. The results of a receiver operator characteristic analysis revealed
that a cocktail ELISA using all five antigens was significantly more sensitive (77.8%) than the use of a single antigen
and offered equivalent specificity; moreover, it produced the largest area under the curve (0.91 versus 0.55 to 0.87).
Therefore, a cocktail ELISA containing abundantly expressed antigens enhances the sensitivity of a single antigen
and can be a useful diagnostic tool for the detection of active TB.
Tuberculosis (TB) is a chronic infectious disease caused by
an intracellular pathogen, Mycobacterium tuberculosis, and is a
major worldwide health problem. According to the World
Health Organization (WHO), one-third of the world’s popu-
lation is latently infected with the bacterium and more than 10
million new cases of TB and 2 million deaths occur across the
globe annually (11). Controlling the incidence of TB depends
on rapid, sensitive diagnostic tests, efficient drug treatment,
and the development of an improved vaccine. Currently,
attenuated Mycobacterium bovis bacillus Calmette-Gue´rin
(BCG) is the only available vaccine against TB, but it has
proven to be problematic because of inconsistent protection
and false-positive results during diagnosis due to cross-reactiv-
ity (4, 12). The purified protein derivative of M. tuberculosis is
the most commonly used antigen for the diagnosis of TB, but
its use is also problematic because of poor specificity due to
cross-reactivity with antigens from other Mycobacterium spe-
cies (36). Thus, an individual’s BCG vaccination status and the
prevalence of environmental mycobacteria are important
factors to consider in the diagnosis of TB.
Since accurate and reliable diagnostic methods for M. tuber-
culosis infection are urgently required for the global control of
this pathogen, the diagnostic potential of M. tuberculosis-spe-
cific antigens has been explored. In an attempt to identify
sensitive and specific serodiagnostic antigens or novel immu-
nogenic antigens of M. tuberculosis, culture filtrates (CFs) from
M. tuberculosis were discovered to contain several highly im-
munogenic antigens that were recognized by the sera of pa-
tients with TB (30, 34). Among those antigens, ESAT-6 and
CFP-10 have been noted for their specificity and sensitivity in
vitro and in vivo for diagnoses based on interferon stimulation
(50, 51). However, the usefulness of these antigens in serodi-
agnosis is greatly limited in terms of sensitivity (73%), al-
though both antigens can be used serologically to distinguish
between TB and other mycobacterial infections (15, 46). Sev-
eral studies have suggested that to improve serum-based meth-
ods for the detection of TB, a cocktail containing the strongest
antigens should be constructed due to the diverse immune
responses of individuals (1, 19, 39). The benefits of using com-
binations of these and other immunogenic antigens should be
investigated to overcome problems with sensitivity during se-
rological diagnostic testing.
In the postgenome era, comparative proteomic techniques
have been used to identify differentially expressed antigens
among endemic, epidemic, and pandemic strains of M. tuber-
culosis in several countries (35, 42). Various studies have
shown numerous differences in protein expression between
different laboratory strains of M. tuberculosis, such as H37Rv
and Erdman (23, 31), and these differences may facilitate a
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better understanding of the mechanisms underlying pathogen-
esis and virulence. Moreover, proteomic analysis of the M.
tuberculosis strain that is prevalent in a particular country will
help to determine which antigens must be considered for the
diagnosis of TB. M. tuberculosis strain K of the Beijing family
is the most-common clinical isolate from TB patients in Korea.
Previous studies identified case clustering among patients with
pulmonary TB from a screen of Korean high school students
(24). The organisms involved in clustered cases of TB are
reported to have increased virulence such that they are able to
spread across broad areas and produce numerous infections
(13).
In this study, we compared the differentially expressed pro-
teins in CFs from M. tuberculosis H37Rv and M. tuberculosis
strain K by using a proteomic approach. We then evaluated the
serodiagnostic potential of five of the antigens (recombinant
antigens rCFP-10, rESAT-6, and rHSP-X and native antigens
Ag85 and PstS1, also known as 30- and 38-kDa antigen) indi-
vidually or in combination by using an enzyme-linked immu-
nosorbent assay (ELISA).
MATERIALS AND METHODS
Bacteria growth and CF antigen preparation. M. tuberculosis H37Rv (ATCC
27294) and M. tuberculosis strain K were initially cultivated in 7H9 broth sup-
plemented with 10% (vol/vol) oleic acid-albumin-dextrose-catalase (OADC;
Becton Dickinson, Cockeysville, MD) for 1 month at 37°C. Single-cell suspen-
sions of each strain were then prepared by agitation in the presence of glass
beads and quantified by plating on 7H10-OADC agar (8). Seed lots of each strain
were kept in small aliquots at 80°C until use.
The CF antigens were produced from each strain by inoculating 100 l of a
seed lot culture containing 109 CFU/ml into 35 ml of modified Watson-Reid
broth (mWR) or Sauton’s synthetic medium (44). After incubation at 37°C for 6
weeks, the bacilli were removed by filtration through filter paper (Whatman
International Ltd., Kent, United Kingdom). The culture supernatants were se-
quentially sterilized by using membrane filters (1.2- and 0.2-m pore size) and
concentrated by ultrafiltration (Amicon ultracentrifugal filter unit with a 3-kDa
molecular-mass cutoff; Millipore, Bedford, MA). The concentration of each CF
antigen was determined by using a bicinchoninic acid protein assay kit (Pierce,
Rockford, IL).
Human sera. To assess the humoral immune response of five proteins (native
30- and 38-kDa antigen plus rHSP-X, rCFP-10, and rESAT-6), serological ex-
periments were conducted using serum samples collected from human immuno-
deficiency virus-seronegative individuals. Sera were obtained from 46 patients
with TB (37 males and 9 females, all Koreans, whose ages ranged from 14 to 80
years) and 46 healthy controls (23 males and 22 females, all Koreans, with a
mean [standard deviation] age of 25  4 years) without a previous history of
clinical TB. Patients with active pulmonary TB (n  46) who had been treated
with anti-TB medications for less than 1 month were enrolled at the Department
of Internal Medicine of Konyang University Hospital (Daejeon, South Korea). A
basic diagnosis of TB was determined by culture and clinical evaluation, such as
chest X-ray results. Only six patients had smear positivity and culture negativity.
None of the subjects had any previous history of diabetes mellitus or steroid
therapy, and all were negative for human immunodeficiency virus. Control sera
were obtained from 45 healthy students at Chungnam National University (Dae-
jeon, South Korea) who had no previous history of clinical TB.
Two-dimensional polyacrylamide gel electrophoresis (PAGE). The CF anti-
gens were prepared by using a two-dimensional clean-up kit (Amersham Bio-
sciences, Uppsala, Sweden). Each sample was separated in the first dimension by
using 7- or 11-cm immobilized pH gradient (IPG) strips with a pH range of 3.9
to 5.1 or 4 to 7 (Bio-Rad, Hercules, CA). The samples were then focused by using
a Protean isoelectric-focusing cell (Bio-Rad) as follows: 250 V for 30 min, from
250 to 4,000 V for 2 h, and 4,000 V for 20,000 Vh in the case of the 7-cm IPG
strip and 250 V for 30 min, from 250 to 8,000 V for 2 h, and 8,000 V for 35,000
Vh in the case of the 11-cm IPG strip. The IPG strips were equilibrated prior to
running in the second dimension. Electrophoresis in the second dimension was
performed as described by Laemmli using 10 to 20% precast gels (Bio-Rad) (25).
The gels were stained with 0.25% Coomassie brilliant blue R250 (Bio-Rad).
Protein identification. The identification of the protein spots on the stained
gels was performed at the Yonsei Proteomics Research Center (Yonsei Univer-
sity, Seoul, South Korea) by liquid chromatography-electrospray ionization-mass
spectrometry (LC-ESI-MS). Briefly, nano-LC–tandem MS (MS-MS) was per-
formed on an Agilent 1100 series nano-LC and LTQ-MS (Thermo Electron, San
Jose, CA). The capillary column used for LC–MS-MS (150 mm by 0.075 mm) was
obtained from Proxeon (Odense, Denmark) and slurry packed in house with a
5-m, 100-Å-pore-size Magic C18 stationary phase (Michrom BioResources,
Auburn, CA). For LC, mobile phase A was 0.1% formic acid in deionized water,
while mobile phase B was 0.1% formic acid in acetonitrile. The chromatographic
gradient was set up to produce a linear increase in B from 5 to 35% over 50 min,
40 to 60% over 20 min, and 60 to 80% over 5 min. The flow rate was maintained
at 300 nl/min after splitting, and mass spectra were acquired by using data-
dependent acquisition with a full mass scan (400 to 1,800 m/z) followed by
MS-MS scans. Each MS-MS scan acquired was an average of one microscan on
the LTQ. The temperature of the ion transfer tube was maintained at 200°C, and
the spray was 1.5 to 2.0 kV. The normalized collision energy was set at 35% for
MS-MS. Sequest software was used to identify the peptide sequences. For high-
confidence results, the following cutoffs were used for protein identification:
deltaCn  0.1, Rsp  4, Xcorr  1.5 with charge state 1, Xcorr  2.0 with
charge state 2, Xcorr 2.5 with charge state 3, and peptide probability 0.1.
The methionine residues in the peptides were variably oxidized, while the cys-
teines were variably carboxyamidomethylated or carboxymethylated.
Antigen preparation. Five antigens (two native and three recombinant) were
prepared. The two native antigens, 30-kDa antigen and 38-kDa antigen, were
purified from M. tuberculosis CFs by using the approach described by Lee et al.,
(27), while the recombinant plasmids encoding esat-6 and hsp-x were provided by
Colorado State University (TB Vaccine Testing and Research Materials); cfp-10
was cloned using pET28. To produce rCFP-10, the corresponding genes were
amplified by PCR using M. tuberculosis strain K genomic DNA as template and
the following primers: forward, 5-GGC CGG GGA TCC ATG GCA GAG
ATG AAG ACC G-3, and reverse, 5-GGC CGG GAA TTC GAA GCC CAT
TTG CGA GGA C-3. The products were cut with BamHI and EcoRI and then
inserted into pET28a. The recombinant plasmids (encoding cfp-10, esat-6, and
hsp-x) were transformed into Escherichia coli BL21 cells carrying bacteriophage
DE3 for protein overexpression. Cultures were grown at 37°C until the optical
density (OD) at 600 nm was 0.4 to 0.5 and then induced with 1 mM isopropyl-
	-D-thiogalactopyranoside (IPTG; ELPIS-Biotech, Daejeon, South Korea). The
cells were then harvested by centrifugation; suspended in 20 mM Tris-HCl (pH
8.0), 0.5 M NaCl, 20 mM imidazole, and 1 mM phenylmethylsulfonyl fluoride
(Sigma, St. Louis, MO); and lysed by sonication. The recombinant proteins were
purified by nickel-nitrilotriacetic acid (Ni-NTA) agarose chromatography in ac-
cordance with the manufacturer’s instructions (Invitrogen, Carlsbad, CA). Each
purification step was analyzed by sodium dodecyl sulfate (SDS)-PAGE with
Coomassie brilliant blue staining and immunoblotting using anti-His antibodies
(Invitrogen).
Antibody production. To obtain antisera for rCFP-10 and rESAT-6, BALB/c
mice were immunized intraperitoneally with purified rCFP-10 and rESAT-6
emulsified in incomplete Freund’s adjuvant. The mice were injected with the
antigen three times at 2-week intervals and were killed 1 week after the final
immunization; thereafter, serum samples were collected and stored at 70°C.
Partial purification of native CFP-10 and ESAT-6 complex. The CFP-10 and
ESAT-6 antigens were partially purified from CFs of M. tuberculosis H37Rv and
strain K by a three-step process. In brief, the 0-to-45% ammonium sulfate
precipitate of CFs was suspended in 50 mM phosphate buffer (pH 6.8) containing
1 M ammonium sulfate and then loaded onto an Econo-Pac methyl HIC car-
tridge (Bio-Rad) for hydrophobic interaction chromatography. The cartridge was
washed with the same buffer and then eluted with a decreasing ammonium
sulfate gradient. The eluates were analyzed by SDS-PAGE. The fractions con-
taining CFP-10 and ESAT-6 complex were pooled and dialyzed against 10 mM
phosphate buffer (pH 6.8). Further purification was performed by anion ex-
change chromatography using gradient elution of 10-to-200 mM phosphate
buffer and hydrophobic interaction chromatography using the same conditions as
for the first step. The final purified antigens were dialyzed against phosphate-
buffered saline (PBS), filter sterilized, and stored at 70°C.
Immunoblotting. Protein transfer from the polyacrylamide gels to nitrocellu-
lose membranes (0.45-m pore size; Bio-Rad) was performed as described by
Davies et al. using a Tris-glycine buffer containing 0.0375% SDS and 20%
methanol (9). Prior to the addition of antigen-specific antibodies or human
serum, the membranes were incubated for 2 h in blocking buffer (5% skim milk
in PBS). The proteins were reacted overnight with the antibodies at 4°C on a
rocking platform. For the detection of CFP-10 and ESAT-6, horseradish perox-
idase (HRP)-conjugated secondary antibodies against mouse immunoglobulin G
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(IgG; Sigma), human serum, and HRP-conjugated secondary antibodies against
human IgG (Sigma) were used. All blots were developed by using 3,3-diamino-
benzidine tetrahydrochloride (Sigma) in 20 mM Tris-buffered saline (pH 7.6)
with 30% hydrogen peroxide (H2O2).
ELISA. ELISA was performed as described by Voller (48). Briefly, polystyrene
96-well microtiter plates (Nunc, Roskilde, Denmark) were coated with different
antigens overnight at 4°C. ESAT-6, CFP-10, 30-kDa antigen, and 38-kDa
antigen, as well as the CFs of M. tuberculosis H37Rv and strain K, were each
added at 1 g/ml (0.1 g/well) in fresh 10 mM PBS (pH 7.4). In each assay,
0.5 g/ml antigen in the same buffer (0.05 g/well) was used. The plates were
washed three times with PBS plus Tween 20 (PBST) and then blocked with
300 l/well of 3% (wt/vol) bovine serum albumin in PBST at room temper-
ature for 2 h. After three more washes, 100 l/well of human serum (1:100
dilution) was added to each plate, and the plates were incubated at room
temperature for 1 h. The plates were then washed as described above, and 100
l of peroxidase-conjugated goat anti-human IgG (1:6,000 dilution; Sigma)
was added to each well; the plates were then incubated for an additional 1 h
at room temperature. After seven more washes, the reaction was visualized by
using tetramethylbenzidine (Sigma) and 0.5% (vol/vol) H2O2. The reaction
was stopped with 1 N sulfuric acid (H2SO4) after 5 min of incubation in the
dark. The OD was measured at 450 nm by using an ELISA microplate reader
(Molecular Devices, Sunnyvale, CA).
Evaluation of tests and statistical analysis. A receiver operator characteristic
(ROC) curve analysis was performed on the ELISA results for each antigen to
determine the cutoff point for distinguishing between a positive and negative
result. Differences in mean ODs for sera from TB patients and healthy subjects
also were evaluated by the Mann-Whitney test. Most statistical analyses were
performed by using statistical software (GraphPad Prism version 4.03 for Win-
dows; GraphPad Software, San Diego, CA). The ELISA area under the ROC
curve (AUC) values were compared by a manual calculation using established
methods (14, 17). An ROC curve (a plot of the true positive rate [% sensitivity]
against the false-positive rate [100%  % specificity] obtained at each cutoff
point) was constructed, and the AUC was determined and compared with the
AUC for the acid-fast bacillus (AFB) smear, which was used as an indicator of
TB in this study.
RESULTS
Comparison of the CFs from M. tuberculosis H37Rv and
strain K by serological testing. The CFs from M. tuberculosis
H37Rv and strain K were tested for their ability to detect anti-
bodies in the sera of 46 patients who were AFB positive with
active pulmonary TB and the sera of 46 healthy controls by
ELISA. Although similarities were observed in terms of sensitivity
and specificity, the results of the ELISA based on the M. tuber-
culosis strain K CF antigens had a higher mean signal-to-noise
(S/N) ratio (mean OD of sera from TB patients/mean OD of sera
from healthy controls) for the patients with TB than those of the
ELISA based on the CF antigens from M. tuberculosis H37Rv
(mean S/N ratio, 3.34 versus 2.06, respectively; P  0.05). In
addition, the CF antigens from M. tuberculosis strain K provided
a more-accurate ELISA based on the ROC AUC than those from
M. tuberculosis H37Rv (Fig. 1). These results suggest that some
serologically important proteins were comparably included in CFs
from M. tuberculosis strain K.
Identification of strongly expressed antigens in the CF ofM.
tuberculosis strain K. To investigate the proteins responsible
for producing the ELISA results, the CF antigen expression
patterns of M. tuberculosis H37Rv and strain K were compared.
Both strains were cultivated in modified Sauton’s (pH 7.2) and
mWR (pH 6.0) medium.
The CF antigens from each strain were separated by two-
dimensional electrophoresis (2-DE) using IPGs. The results of
pilot experiments revealed differential expression of several M.
tuberculosis proteins in the two strains at a pH of 4 to 7 (Fig.
FIG. 1. Antibody responses to CFs of M. tuberculosis strain K and M. tuberculosis H37Rv using ELISA. The CFs were tested against the sera
of 46 patients who were AFB positive with active pulmonary TB and 46 healthy controls. All results are expressed in terms of the S/N ratio (A) and
were compared by ROC analysis (B). Significantly higher antibody responses to the CF from M. tuberculosis strain K than to the CF from strain
H37Rv were detected (AUC  0.91).
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2A). Those spots with comparable intensities were then ex-
panded by using a pH range of 3.9 to 5.1 and 11-cm IPG strips
(Fig. 2B). A similar protein expression pattern was observed
regardless of the culture medium; moreover, the differential
protein expression between the two strains was most striking at
a molecular mass of 20 kDa. The different protein spots in
the low-molecular-weight region were further analyzed and
identified by LC-ESI-MS. The results of proteomic analysis
identified three proteins that were abundantly expressed in M.
tuberculosis strain K: CFP-10 (Rv3874), Hsp-X (Rv2031c), and
ESAT-6 (Rv3875) (Fig. 2A). The relative abundance of these
proteins in the strain K CF was confirmed by 2-DE–immuno-
blot analysis following cultivation in both media. Although the
patterns produced by 2-DE of the CF proteins from the mWR
medium-cultivated cells were somewhat different from those of
the CF proteins from the Sauton’s medium-cultivated cells,
abundant CFP-10 and ESAT-6 expression in the CF of M.
tuberculosis strain K was verified by immunoblot analysis (see
Fig. 4D and E). Note that the continuous subculture of M.
tuberculosis strain K in broth medium for more than 6 months
resulted in decreased expression of all three proteins (data not
shown).
To confirm once again if the CFP-10 and ESAT-6 proteins
were more abundantly expressed in strain K than H37Rv, the
proteins were partially purified from CFs of M. tuberculosis
H37Rv and strain K and analyzed by using 2-DE and immu-
noblotting. The native CFP-10 and ESAT-6 were copurified, as
demonstrated previously. On analysis of purified proteins from
both strains by 2-DE (Fig. 3A) and immunoblotting using anti-
CFP-10 antibody (Fig. 3B) and anti-ESAT-6 antibody (Fig.
3C), we observed again that the CFP-10 and ESAT-6 proteins
were more abundantly present in strain K than in strain
H37Rv.
Expression, purification, and confirmation of rCFP-10,
rHsp-X, and rESAT6. To compare the serological reactivities
of ESAT-6, CFP-10, and HSP-X, each protein was expressed
as a six-His-tagged fusion protein in E. coli BL21 cells and then
purified by Ni-NTA affinity chromatography. SDS-PAGE of
the recombinant proteins revealed major bands at approxi-
mately 6, 10, and 16 kDa, respectively (Fig. 4A to C). rCFP-10
and rESAT-6 were confirmed by comparing them with the
native proteins using immunoblot analysis (Fig. 4D and E).
Individual variation in the antibody response to five myco-
bacterial antigens. We next investigated the serological poten-
tial of ESAT-6, CFP-10, and HSP-X; two native proteins fre-
quently used in serological tests were also included (Table 1).
ESAT-6, HSP-X, and CFP-10 were abundantly expressed in
the CF of M. tuberculosis strain K, as were the 30- and 38-kDa
antigens, suggesting that they are strong candidates for use in
improved serodiagnostic tests for TB. We confirmed that each
antigen had the correct band composition; a mixture of the five
FIG. 2. 2-DE analysis of CFs of M. tuberculosis strain K and M.
tuberculosis H37Rv. (A) CFs were isolated from tubercle bacilli grow-
ing in Sauton’s synthetic medium and concentrated. The concentrated
CFs (300 g) were then separated by isoelectric focusing using a 7-cm
pH gradient strip (pH 4 to 7) in the first dimension and 15% SDS-
PAGE in the second dimension. (B) To enlarge the boxed regions in
the gels, the proteins were separated again by isoelectric focusing on
11-cm IPG strips (pH 3.9 to 5.1) in the first dimension and 10-to-20%
gradient SDS-PAGE in the second dimension. The proteins were
stained with 0.25% Coomassie brilliant blue R250, and the spots were
identified by LC-ESI-MS.
FIG. 3. 2-DE and immunoblot analysis of partially purified native
CFP-10 and ESAT-6 complex from M. tuberculosis H37Rv and M.
tuberculosis strain K. The purified native proteins (250 g) were sep-
arated by isoelectric focusing on 7-cm IPG strips (pH gradient of 3.9 to
5.1) in the first dimension and 15% SDS-PAGE in the second dimen-
sion. The proteins were analyzed by staining with 0.25% Coomassie
brilliant blue R250 (A) and immunoblotting with anti-CFP-10 (B) and
anti-ESAT-6 (C) polyclonal antibodies.
FIG. 4. (A to C) Immunoblot analysis of rCFP-10 and rESAT-6.
Six-His-tagged rESAT-6 (A), rCFP-10 (B), and rHSP-X (C) were
expressed in E. coli cells, purified by Ni-NTA affinity chromatography,
and subjected to SDS-PAGE with Coomassie brilliant blue staining.
(D and E) Concentrated CFs from M. tuberculosis strain K (lane 1) and
H37Rv (lane 2) were analyzed by immunoblotting with rabbit anti-
CFP-10 (D) and mouse anti-ESAT-6 (E) polyclonal antibodies. Each
lane was loaded with 30 g of proteins. The positions of the molecular
standards are shown by bars.
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antigens contained five major bands, while native 30-kDa an-
tigen consisted of three proteins (the Ag85 complex) (Fig. 5A).
The individual antibody response to an antigen cocktail con-
sisting of the five mycobacterial proteins was investigated by
immunoblot analysis. When the antigens were compared indi-
vidually, the highest antibody response was obtained for native
30-kDa antigen, which was able to detect 40.0% (18 of 45) of
the samples from patients with AFB-positive pulmonary TB. A
total of 28 sera reacted to at least one antigen (64.4%), while
6 sera (13.3%) reacted to one of the following: ESAT-6, CFP-
10, or HSP-X (Fig. 5B). The multiple additional bands seen in
Fig. 5B resulted from minor proteins contaminated in purified
native Ag85 complex.
Improved diagnostic sensitivity using all five proteins to
create a cocktail ELISA. To evaluate rCFP-10, rESAT-6, and
rHSP-X for the serodiagnosis of TB, the human serum IgG
level against five antigens (purified rCFP-10, rESAT-6, and
rHSP-X and native 30- and 38-kDa antigen) alone or in com-
bination was measured by indirect ELISA using serum samples
from 46 patients with active pulmonary TB and 46 healthy
controls. All of the antigens tested evoked a significantly higher
IgG antibody response in the TB group than in the control
group (P  0.001). The greatest AUC value and diagnostic
accuracy for a single antigen was obtained using rHSP-X (Ta-
ble 2). A cocktail ELISA using all five antigens had a higher
diagnostic sensitivity than the use of a single antigen (77.8
versus 67.4%) and had equivalent specificity. The results of
ROC analysis revealed that the cocktail ELISA also produced
the largest AUC (Table 2).
DISCUSSION
Serological tests are attractive for the screening or diagnosis
of TB disease or infection because they are quick and relatively
TABLE 1. Antigens used in this study
Antigen Rv no. Molecularsize (kDa) Features
a Form used
CFP-10 Rv3874 10 Induced strong T-cell response Recombinant
ESAT-6 Rv3875 6 Heterodimer in tight 1:1 complex Recombinant
HSP-X Rv2031c 16 Alpha-crystallin, heat shock protein Recombinant
Ag85 complex Ag85A, Rv3804c; Ag85B, Rv1886c;
Ag85C, Rv0129c
30–32 Secretory antigen, induced IFN-
,
IL-12p40, and IL-18 production
Native
PstS1 Rv0934 38 Required for phosphate uptake
and virulence
Native
a IFN-
, gamma interferon; IL-12 and -18, interleukin-12 and -18.
FIG. 5. Variability among the immunoblot profiles of the five antigens. (A) Five antigens, including two native antigens (30- and 38-kDa
antigen) and three recombinant antigens (rESAT-6, rCFP-10, and rHSP-X), were subjected to SDS-PAGE and Coomassie blue staining. Lane 1,
rESAT-6; lane 2, rCFP-10; lane 3, rHSP-X; lane 4, native 30-kDa antigen; lane 5, native 38-kDa antigen; lane 6, cocktail of the five antigens; lane
M, molecular-mass marker. (B) To investigate the reactivity of the five-antigen cocktail against sera from 45 individuals infected with M.
tuberculosis, each lane was loaded with the same concentration of cocktail (180 g of each protein). Following 15% SDS-PAGE and protein
transfer to nitrocellulose, the sera were applied (1:200 dilution). Subsequently, the membranes were incubated with anti-human IgG HRP
conjugate (1:2,000 dilution) and developed using diaminobenzidine.
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simple to perform (6). However, to develop an effective im-
munological test for TB, one must avoid cross-reactivity with
BCG or nontuberculous mycobacteria (4, 12). As a result,
researchers are constantly searching for novel immunogenic
antigens. A high number of M. tuberculosis antigens induce
specific humoral and cellular immune responses, and these
antigens have been shown to be correlated with proven cases of
TB in humans. Previous studies aimed at developing a TB
vaccine or immunodiagnostic techniques have focused on the
CF antigens released from M. tuberculosis because of their
immunogenicity (30, 34). In this study, ROC analysis of the CF
antigens from M. tuberculosis strain K had a higher mean
ELISA S/N ratio and more-accurate AUC than ROC analysis
of those from M. tuberculosis strain H37Rv. Thus, several of
the proteins in the CF from M. tuberculosis strain K may be
useful for immunological testing. M. tuberculosis strain K,
which belongs to the Beijing family, has been recognized as the
most-influential and -prevalent clinical isolate contributing to
TB in Korea (24). Consequently, we used a proteomics-based
approach to screen for novel strain K antigens that may be
useful in the diagnosis of TB. We identified three proteins,
HSP-X, CFP-10, and ESAT-6, which were expressed at rela-
tively higher levels in the CF of strain K than in that of strain
H37Rv. In particular, CFP-10 and ESAT-6 were abundantly
expressed in the CF from strain K, despite the genes encoding
CFP-10 and ESAT-6 in both strains of M. tuberculosis being
identical. Although some proteins were more abundantly ex-
pressed in CF antigens from H37Rv than those from strain K
(Fig. 2), we were only interested in highly expressed proteins in
strain K. Therefore, we did not identify these proteins.
HSP-X is a 16-kDa heat shock protein required for the
persistence and growth of mycobacteria within host macro-
phages in hypoxic microenvironments and is the dominant
antigen induced under conditions of reduced O2 tension (10,
45). CFP-10 (a 10-kDa CF protein) and ESAT-6 (a 6-kDa early
secretory antigenic target), both of which are secreted from M.
tuberculosis, are well-known T-cell-stimulating antigens that
lack traditional signal sequences and are exported through an
ESX-1 secretion system encoded by region of difference 1
(RD1) (16, 32, 40). RD1, which consists of nine genes, is
absent from attenuated or avirulent strains, such as M. bovis
BCG and Mycobacterium microti, but is present in all virulent
isolates. In previous comparative proteomic analyses of the CF
proteins from M. tuberculosis K and other virulent strains,
CDC1551, ESAT-6, and CFP-10 were included among the CF
antigens of the virulent strains more often than among those of
strain H37Rv, which is in good agreement with our findings
(5). In addition, we found that the abundance of ESAT-6 and
CFP-10 in the CF from M. tuberculosis strain K decreased
following continuous subculture. Taken together, our results
suggest that virulent or recently isolated clinical samples of M.
tuberculosis produce these proteins at higher levels than labo-
ratory-adapted strains, such as H37Rv. Testing whether the
virulence of M. tuberculosis strain K can be reduced by contin-
uous serial passage may prove interesting.
CFP-10 and ESAT-6 from the two strains were detected at
multiple spots with similar or different masses and different pI
values by 2-DE. CFP-10 and ESAT-6 are usually bound to-
gether as a heterodimer, but the CFP-10:ESAT-6 complex
dissociates upon the N-terminal acetylation of ESAT-6 (37,
41). The posttranslational modification of ESAT-6 by acetyla-
tion has been shown in several studies (38, 43).
After confirming the strong expression of ESAT-6, CFP-10,
and HSP-X in the CF of M. tuberculosis strain K, we performed
a series of serological tests that included the three proteins
plus two native antigens, Ag85 complex and PstS1. Antigen 85
is primarily a candidate for a vaccine against TB, while PstS1
has been commonly pursued for its potential as a serodiagnos-
tic antigen. These antigens induce a strong immune response
to M. tuberculosis and elicit a protective immune response in
animals and humans (3, 18, 21). The Ag85 complex (Ag85A,
Ag85B, and Ag85C) includes the 30- and 32-kDa antigens,
which are major secretory antigens of M. tuberculosis that ex-
hibit mycolyl transferase activity (49). In comparison, PstS1 (a
phosphate-specific ABC transporter) is a 38-kDa lipoglyco-
protein that may be found as part of a membrane-associated
complex or secreted in mycobacterial cultures (7, 20).
Our ELISA results revealed a significantly higher IgG anti-
body response to all five antigens (CFP-10, ESAT-6, HSP-X,
Ag85 complex, and PstS1) in the TB group than in the control
group. The greatest AUC and diagnostic accuracy for a single
antigen was obtained using HSP-X, whereas the reactivity of
30-kDa antigen (i.e., the Ag85 complex) was the strongest
among the five antigens in the immunoblot analysis. During
Western blotting, the denatured proteins were probably unable
to react normally to the Ig due to the loss of their natural
structure or epitope. Thus, the three-dimensional conforma-
tion of HSP-X may be important for immunological test de-
velopment. Serological testing for M. tuberculosis using a cock-
tail of antigens may lead to improved sensitivity (29, 33). Not
only the antigen 85 complex and PstS1 (26), but also lipoarabi-
nomannan (22), 34-kDa antigen (2), MTC28, ES-31 and ES-43
from an M. tuberculosis H37Ra CF (19), 19-kDa lipoprotein,
KatG, and 14-kDa antigen (28, 47) were previously reported to
be useful for the detection of TB. In the present study, we
confirmed that a cocktail of two well-known potential diagnos-
tic antigens (native Ag85 complex and PstS1) and three addi-
tional antigens (rCFP-10, rESAT-6, and rHSP-X) yielded the
highest analytical sensitivity. These findings agree with those of
previous studies showing that a cocktail of antigens increased
the diagnostic sensitivity of serological tests for TB compared
to the use of a single antigen.
An important result from this study is the specific CFP-10 or
TABLE 2. Overall comparison using a single antigen alone or
combination of all antigens in ELISA for diagnosis of
active tuberculosis
Antigen Cutoffvaluea Sensitivity
AUC (95% confidence
interval)
Avg S/N
ratiob
CFP-10 0.23 45.87 0.8896 (0.8243–0.9549) 2.45
ESAT-6 0.22 36.96 0.7543 (0.6544–0.8543) 1.86
HSP-X 0.38 67.36 0.9058 (0.8466–0.9650) 3.38
Ag85
complex
0.27 47.83 0.8782 (0.8324–0.9302) 3.13
PstS1 0.18 56.52 0.899 (0.8372–0.9609) 3.15
Combination 0.21 77.78 0.9123 (0.8410–0.9836) 3.619
a Cutoff values for each ELISA were determined when the specificity was
100%.
b The S/N ratio was considered the standard for overall comparison of anti-
body response.
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HSP-X antigen-antibody response. Among the individuals in
the TB group, several showed either a CFP-10 or HSP-X
antigen-specific antibody response by ELISA and immunoblot
analysis. In other words, CFP-10 and HSP-X may further in-
crease the clinical sensitivity of serological tests and help iden-
tify patients that do not react to 30- or 38-kDa antigen.
In conclusion, the abundantly expressed immunogenic anti-
gens of geographically prevalent strains of M. tuberculosis may
be important for the development of serodiagnostic tests for
TB; moreover, ESAT-6, CFP-10, and HSP-X may be used to
increase assay sensitivity when included alongside well-known
serological antigens for the detection of M. tuberculosis infec-
tion.
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